These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 24521774)

  • 1. Impact of targeted antifungal prophylaxis in heart transplant recipients at high risk for early invasive fungal infection.
    Tissot F; Pascual M; Hullin R; Yerly P; Tozzi P; Meylan P; Manuel O
    Transplantation; 2014 Jun; 97(11):1192-7. PubMed ID: 24521774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caspofungin as primary antifungal prophylaxis in stem cell transplant recipients.
    Chou LS; Lewis RE; Ippoliti C; Champlin RE; Kontoyiannis DP
    Pharmacotherapy; 2007 Dec; 27(12):1644-50. PubMed ID: 18041885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology, risk factors, and association of antifungal prophylaxis on early invasive fungal infection in heart transplant recipients.
    Yetmar ZA; Lahr B; Brumble L; Gea Banacloche J; Steidley DE; Kushwaha S; Beam E
    Transpl Infect Dis; 2021 Oct; 23(5):e13714. PubMed ID: 34435415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal prophylaxis in liver transplant recipients: one size does not fit all.
    Giannella M; Bartoletti M; Morelli M; Cristini F; Tedeschi S; Campoli C; Tumietto F; Bertuzzo V; Ercolani G; Faenza S; Pinna AD; Lewis RE; Viale P
    Transpl Infect Dis; 2016 Aug; 18(4):538-44. PubMed ID: 27237076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simplified regimen of targeted antifungal prophylaxis in liver transplant recipients: A single-center experience.
    Lavezzo B; Patrono D; Tandoi F; Martini S; Fop F; Ballerini V; Stratta C; Skurzak S; Lupo F; Strignano P; Donadio PP; Salizzoni M; Romagnoli R; De Rosa FG
    Transpl Infect Dis; 2018 Apr; 20(2):e12859. PubMed ID: 29427394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of invasive fungal infections in lung transplant recipients on long-term azole antifungal prophylaxis.
    Chong PP; Kennedy CC; Hathcock MA; Kremers WK; Razonable RR
    Clin Transplant; 2015 Apr; 29(4):311-8. PubMed ID: 25604399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for recurrence of invasive fungal infection during secondary antifungal prophylaxis in allogeneic hematopoietic stem cell transplant recipients.
    Liu F; Wu T; Wang JB; Cao XY; Yin YM; Zhao YL; Lu DP
    Transpl Infect Dis; 2013 Jun; 15(3):243-50. PubMed ID: 23496156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized trial of micafungin for the prevention of invasive fungal infection in high-risk liver transplant recipients.
    Saliba F; Pascher A; Cointault O; Laterre PF; Cervera C; De Waele JJ; Cillo U; Langer RM; Lugano M; Göran-Ericzon B; Phillips S; Tweddle L; Karas A; Brown M; Fischer L; ;
    Clin Infect Dis; 2015 Apr; 60(7):997-1006. PubMed ID: 25520332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary antifungal prophylaxis in pediatric hematopoietic stem cell transplants.
    Azik FM; Tezer H; Ozkaya-Parlakay A; Aksu T; Bayram C; Fettah A; Tavil B; Tunç B
    J Pediatr Hematol Oncol; 2015 Jan; 37(1):e19-22. PubMed ID: 25522351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematopoietic SCT in patients with a history of invasive fungal infection.
    Zhang P; Song A; Wang Z; Feng S; Qiu L; Han M
    Bone Marrow Transplant; 2009 Apr; 43(7):533-7. PubMed ID: 19104496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Universal prophylaxis with fluconazole for the prevention of early invasive fungal infection in low-risk liver transplant recipients.
    San-Juan R; Aguado JM; Lumbreras C; Fortun J; Len O; Muñoz P; Montejo M; Moreno A; Cordero E; Blanes M; Ramos A; de la Torre-Cisneros J; Lopez-Medrano F; Carratala J; Moreno E;
    Transplantation; 2011 Aug; 92(3):346-50. PubMed ID: 21709604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating prophylaxis of invasive fungal infections in patients with haematologic malignancies.
    Maertens J
    Eur J Haematol; 2007 Apr; 78(4):275-82. PubMed ID: 17241370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective analysis of the use of caspofungin in recipients of liver transplant with a modified high index of suspicion for fungal infection. A critical review of mortality, acute cellular rejection, infections, and changes in the liver function tests while on caspofungin.
    Doria C; Bodzin AS; Vaccino S; Daskalakis C; Krawitz S; Ramirez CB
    Clin Transplant; 2011; 25(4):569-75. PubMed ID: 20662881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of invasive fungal infections after liver transplantation and the risk factors of late-onset invasive aspergillosis.
    Nagao M; Fujimoto Y; Yamamoto M; Matsumura Y; Kaido T; Takakura S; Uemoto S; Ichiyama S
    J Infect Chemother; 2016 Feb; 22(2):84-9. PubMed ID: 26683245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study.
    Rinaldi M; Bartoletti M; Ferrarese A; Franceschini E; Campoli C; Coladonato S; Pascale R; Tedeschi S; Gatti M; Cricca M; Ambretti S; Siniscalchi A; Morelli MC; Cescon M; Cillo U; Di Benedetto F; Burra P; Mussini C; Cristini F; Lewis R; Viale P; Giannella M
    Transpl Infect Dis; 2021 Aug; 23(4):e13608. PubMed ID: 33768656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years.
    Hovi L; Saarinen-Pihkala UM; Vettenranta K; Saxen H
    Bone Marrow Transplant; 2000 Nov; 26(9):999-1004. PubMed ID: 11100280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
    Neofytos D; Horn D; Anaissie E; Steinbach W; Olyaei A; Fishman J; Pfaller M; Chang C; Webster K; Marr K
    Clin Infect Dis; 2009 Feb; 48(3):265-73. PubMed ID: 19115967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caspofungin as first-line therapy for the treatment of invasive aspergillosis after thoracic organ transplantation.
    Groetzner J; Kaczmarek I; Wittwer T; Strauch J; Meiser B; Wahlers T; Daebritz S; Reichart B
    J Heart Lung Transplant; 2008 Jan; 27(1):1-6. PubMed ID: 18187079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive fungal infections in pediatric heart transplant recipients: incidence, risk factors, and outcomes.
    Zaoutis TE; Webber S; Naftel DC; Chrisant MA; Kaufman B; Pearce FB; Spicer R; Dipchand AI;
    Pediatr Transplant; 2011 Aug; 15(5):465-9. PubMed ID: 21108712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal therapy in patients with hematological malignancies: how to avoid overtreatment?
    Cherif H; Kalin M; Björkholm M
    Eur J Haematol; 2006 Oct; 77(4):288-92. PubMed ID: 16856930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.